- About |
- Contact Us |
- Site Map |
- Privacy Policy |
- Terms Of Use |
- Feedback
Cost-Effective Interventions
Interventions are actions taken by or for individuals to reduce the risk, duration, or severity of adverse health conditions. Interventions may be population-based or personal.
DCP2 and GBD present what we know about which health interventions work for a comprehensive range of diseases, injuries, and disabilities in many different contexts. A large share of the disease burden in low- and middle-income countries is attributable to diseases and conditions for which cost-effective interventions are already known and feasible. Selecting the right intervention for a given disease and context matters a great deal. The tools on this page are designed to aid the task.
DCP2 and GBD demonstrate how decision makers could use cost-effectiveness information in combination with information on disease prevalence and avertable illness to determine which interventions should be extended and which ones should be questioned. If developing countries scale up interventions and extend health care services that are cost-effective, the impact on the disease burden could be substantial.
Select Criteria
Download Results (CSV) | Download Full Data Set (XLS)
| Condition | Intervention | Intervention type | Intervention description | Intervention setting | Objective | Target population | Cost effectiveness (US$/DALY) | Cost effectiveness estimate (US$) | Cost effectiveness range (US$/DALY) | Number of DALYs averted (hundreds) | Number of deaths averted (hundreds) | Quality of cost-effectiveness analysis evidence |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HIV/AIDS | Antiretroviral therapy | Personal | Combination therapy with multiple antiretroviral drugs associated with prolonged survival in treated patients | Clinic | primary prevention | All ages, Adults, Infants or children, Women of childbearing age, Pregnant women, Adolescents and adults, Mothers and infants | 922 (SubSaharan Africa) | - | 350-1,494 (SubSaharan Africa) | -- | -- | 3 (Sub-Saharan Africa) |
| HIV/AIDS | Blood and needle safety | Population | Screening of all blood for transfusions; sterilization for all injections; harm reduction for injecting drug users, including needle exchange and drug substitution programs | Community, Clinic, Referral hospital, Local or district hospital | population-oriented medical intervention | All ages, Adults, Infants or children, Women of childbearing age, Pregnant women, Adolescents and adults, Mothers and infants | 84 (Sub-Saharan Africa) | - | 7-161 (SubSaharan Africa) | -- | -- | 2 (SubSaharan Africa) |
| HIV/AIDS | Condom promotion and distribution | Population | Targeted distribution and placement of condoms in locations such as bars or brothels; distribution linked to voluntary counseling and testing and sexually transmitted infection care to ensure universal access; information, education, and communication, in | Community, Clinic | personal behavior change | Adults, Women of childbearing age, Pregnant women, Adolescents and adults | 82 (Sub-Saharan Africa) | - | 52-112 (SubSaharan Africa) | -- | -- | 1 (SubSaharan Africa) |
| HIV/AIDS | Home care | Personal | Home visits providing basic care to sick AIDS patients or comprehensive schemes that provide palliative care, nutrition, psychosocial support and counseling, and links to primary and secondary health care | Home | secondary prevention, palliation | All ages, Adults, Infants or children, Women of childbearing age, Pregnant women, Adolescents and adults, Mothers and infants | 673 (SubSaharan Africa) | - | -- | -- | -- | 2 (Sub-Saharan Africa) |
| HIV/AIDS | Mother-to-child transmission prevention | Personal | All pregnant women offered screening to prevent mother-tochild transmission; administration of a short-course of AZT, lamivudine, or nevirapine to mothers prepartum and intrapartum and to newborns postpartum to reduce the risk of motherto-child transmissi | Clinic | primary prevention | Infants or children, Women of childbearing age, Pregnant women, Mothers and infants | 192 | - | 7-377 | -- | -- | 2 |
| HIV/AIDS | Peer and education programs for high-risk groups | Population | Targeting community members (for example, students or commercial sex workers) to disseminate information and teach specific skills | Community | personal behavior change | Adults, Women of childbearing age, Pregnant women, Adolescents and adults | 37 | - | 6-68 | -- | -- | 2 |
| HIV/AIDS | Sexually transmitted infection diagnosis and treatment | Personal | Sexually transmitted infection screening and treatment promotion to prevent future infection and to identify and treat highrisk populations | Clinic | primary prevention, cure | Adults, Women of childbearing age, Pregnant women, Adolescents and adults | 57 (SubSaharan Africa) | - | 9-105 (SubSaharan Africa) | -- | -- | 2 (Sub-Saharan Africa) |
| HIV/AIDS | Treatment of Kaposi's sarcoma | Personal | Treatment before or after antiretroviral treatment, including failed antiretroviral treatment; local or systemic treatment of lesions to provide largely cosmetic benefit | Clinic, Local or district hospital | primary prevention, palliation | All ages, Adults, Infants or children, Women of childbearing age, Pregnant women, Adolescents and adults, Mothers and infants | 52,449 | - | 34,968-69,930 | -- | -- | 3 |
| HIV/AIDS | Treatment of opportunistic infections | Personal | Opportunistic infection prophylaxis; necessary for patients without access to antiretroviral treatment, for immunosuppressed patients waiting for antiretroviral treatment to take effect, for patients who refuse or cannot take antiretroviral treatment, for | Clinic, Local or district hospital | primary prevention, cure | All ages, Adults, Infants or children, Women of childbearing age, Pregnant women, Adolescents and adults, Mothers and infants | 156 | - | 3-310 | -- | -- | 3 |
| HIV/AIDS | Tuberculosis coinfection prevention and treatment | Personal | Preventive therapy, short-course chemotherapy, or co-trimoxazole prophylaxis | Clinic | primary prevention, cure | All ages, Adults, Infants or children, Women of childbearing age, Pregnant women, Adolescents and adults, Mothers and infants | 121 (SubSaharan Africa) | - | 6-235 (SubSaharan Africa) | -- | -- | 2 (Sub-Saharan Africa) |
| HIV/AIDS | Voluntary counseling and testing | Population | Routine and voluntary confidential HIV counseling and testing | Clinic | population-oriented medical intervention | Adults, Women of childbearing age, Pregnant women, Adolescents and adults | 47 | - | 10-85 | -- | -- | 2 |
